Creative Planning’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-182
| Closed | -$9K | – | 2496 |
|
|
2022
Q1 | $9K | Hold |
182
| – | – | ﹤0.01% | 2202 |
|
|
2021
Q4 | $8K | Sell |
182
-6
| -3% | -$321 | ﹤0.01% | 2065 |
|
|
2021
Q3 | $12K | Buy |
188
+5
| +3% | +$379 | ﹤0.01% | 2066 |
|
|
2021
Q2 | $18K | Sell |
183
-448
| -71% | -$46.2K | ﹤0.01% | 1990 |
|
|
2021
Q1 | $81K | Sell |
631
-120
| -16% | -$17.7K | ﹤0.01% | 2284 |
|
|
2020
Q4 | $83K | Sell |
751
-5
| -0.7% | -$560 | ﹤0.01% | 2052 |
|
|
2020
Q3 | $89K | Buy |
756
+297
| +65% | +$51.4K | ﹤0.01% | 1841 |
|
|
2020
Q2 | $98K | Hold |
459
| – | – | ﹤0.01% | 1666 |
|
|
2020
Q1 | $104K | Buy |
459
+4
| +0.9% | +$1.14K | ﹤0.01% | 1523 |
|
|
2019
Q4 | $122K | Hold |
455
| – | – | ﹤0.01% | 1733 |
|
|
2019
Q3 | $138K | Buy |
455
+4
| +0.9% | +$1.23K | ﹤0.01% | 1677 |
|
|
2019
Q2 | $149K | Hold |
451
| – | – | ﹤0.01% | 1684 |
|
|
2019
Q1 | $282K | Buy |
451
+26
| +6% | +$11.9K | ﹤0.01% | 1362 |
|
|
2018
Q4 | $106K | Hold |
425
| – | – | ﹤0.01% | 1623 |
|
|
2018
Q3 | $197K | Sell |
425
-14
| -3% | -$6.78K | ﹤0.01% | 1685 |
|
|
2018
Q2 | $238K | Hold |
439
| – | – | ﹤0.01% | 1520 |
|
|
2018
Q1 | $252K | Hold |
439
| – | – | ﹤0.01% | 1458 |
|
|
2017
Q4 | $281K | Hold |
439
| – | – | ﹤0.01% | 1402 |
|
|
2017
Q3 | $413K | Hold |
439
| – | – | ﹤0.01% | 1139 |
|
|
2017
Q2 | $383K | Hold |
439
| – | – | ﹤0.01% | 1158 |
|
|
2017
Q1 | $302K | Hold |
439
| – | – | ﹤0.01% | 1258 |
|
|
2016
Q4 | $316K | Sell |
439
-45
| -9% | -$31.1K | ﹤0.01% | 1162 |
|
|
2016
Q3 | $357K | Hold |
484
| – | – | ﹤0.01% | 1080 |
|
|
2016
Q2 | $403K | Sell |
484
-9
| -2% | -$8.37K | ﹤0.01% | 888 |
|
|
2016
Q1 | $408K | Buy |
493
+18
| +4% | +$14.1K | ﹤0.01% | 835 |
|
|
2015
Q4 | $535K | Buy |
475
+4
| +0.8% | +$4.65K | ﹤0.01% | 723 |
|
|
2015
Q3 | $399K | Buy |
471
+23
| +5% | +$33.3K | ﹤0.01% | 833 |
|
|
2015
Q2 | $794K | Buy |
448
+13
| +3% | +$16.5K | 0.01% | 540 |
|
|
2015
Q1 | $523K | Buy |
435
+24
| +6% | +$28.1K | ﹤0.01% | 719 |
|
|
2014
Q4 | $465K | Buy |
411
+41
| +11% | +$42.1K | ﹤0.01% | 732 |
|
|
2014
Q3 | $372K | Hold |
370
| – | – | ﹤0.01% | 773 |
|
|
2014
Q2 | $488K | Hold |
370
| – | – | 0.01% | 654 |
|
|
2014
Q1 | $515K | Hold |
370
| – | – | 0.01% | 601 |
|
|
2013
Q4 | $425K | Buy |
+370
| New | +$510K | 0.01% | 566 |
|
Other funds holding RMTI
RB
PCM
VCA
SW
Creative Planning's RMTI Position: Q2 2022 in Review
Creative Planning sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 182 shares — an estimated $9K sold.
Creative Planning first reported a position in RMTI in Q4 2013 and held it in 34 quarters. The position peaked at $794K in Q2 2015. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.
- Creative Planning reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
- Creative Planning sold 182 Rockwell Medical shares in Q2 2022, an estimated $9K.
- Creative Planning first reported a position in Rockwell Medical in Q4 2013 and held it in 34 quarters.
- Creative Planning's Rockwell Medical position peaked at $794K in Q2 2015.
- 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.
Based on Creative Planning's 13F filing for Q2 2022, filed 15 Aug 2022.